Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Relapsed CLL and Untreated 11q CLL
NCT01750567Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Nov 2012
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liquid metformin (Aspargo Labs) in chronic lymphocytic leukemia (CLL), sponsored by University of Michigan Rogel Cancer Center. Primary endpoint: Time to Treatment Failure. Started Nov 2012; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01750567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750567.